Research Article

Clinical Findings in Diabetes Mellitus Patients with COVID-19

Table 3

Treatment and outcomes of DM patients with COVID-19.

Total ()ICU ()Non-ICU ()

Complications7 (36.8%)4 (57.1%)3 (25.0%)
 Acute cardiac injury1 (5.3%)1 (14.3%)0
 Acute liver injury5 (26.3%)2 (28.6%)3 (25.0%)
 Allergic eruption1 (5.3%)1 (14.3%)0
Treatment
 Antivirals18 (94.7%)7 (100.0%)11 (91.7%)
 Antibiotics6 (31.6%)6 (85.7%)0
 Corticosteroid7 (36.8%)6 (85.7%)1 (8.3%)
 Immunoglobulin6 (31.6%)6 (85.7%)0
 Insulin8 (42.1%)7 (100.0%)1 (8.3%)
Oxygen support
 Nasal cannula14 (73.7%)4 (57.1%)10 (83.3%)
 High-flow nasal cannula3 (15.85)3 (42.9%)0
Time from symptoms onset to negative RT-PCR result, days22.6 (8-50)30.6 (19-50)17.9 (8-31)

Data are presented as mean (range) or (%). Abbreviations: DM: diabetes mellitus; RT-PCR: reverse transcription-polymerase chain reaction.